ANDA 40735, held by Pharmobedient. Hydrochlorothiazide.
As of Nov 15, 2026, ANDA 40735 (Hydrochlorothiazide), held by Pharmobedient, was first approved by FDA on Jan 23, 2007, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 23, 2007 | Original application | Approved | None posted |
| Hydrochlorothiazide25MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Hydrochlorothiazide50MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Aug 20, 2020 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 17, 2011 | Supplement 4Labeling | Approved | |
| Jan 23, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
